SCHEMBL25459696

SCHEMBL25459696

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4nc(-c5cccc(-c6cccc7c6sc6c(-c8ccccc8)cccc67)c5)oc4c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VSIR Q9H7M9 6/20 0.44
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
MAPT P10636 5/20 0.41
NPC1 O15118 4/20 0.41
ALDH1A1 P00352 4/20 0.41
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ESR1 P03372 3/20 0.41
ESR2 Q92731 3/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
GPR119 Q8TDV5 5/20 0.40
TP53 P04637 3/20 0.40
GAA P10253 2/20 0.40
LMNA P02545 1/20 0.40
NFKB1 P19838 1/20 0.40
STAT1 P42224 1/20 0.40
GFER P55789 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459644 0.94 NPC1 (0.44) VSIRMAPTNPC1ALDH1A1RAB9A
SCHEMBL21890971 0.94 VSIR (0.44) VSIRPDCD1CD274MAPTNPC1
SCHEMBL25459695 0.93 ALOX5 (0.46) VSIRPDCD1CD274MAPTNPC1
SCHEMBL25459500 0.91 HPSE (0.43) MAPTNPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL25459643 0.90 NPC1 (0.44) VSIRMAPTNPC1ALDH1A1RAB9A
SCHEMBL25459653 0.89 RAB9A (0.41) VSIRPDCD1CD274MAPTNPC1
SCHEMBL23473651 0.88 ALOX5 (0.40) VSIRMAPTNPC1ALDH1A1RAB9A
SCHEMBL25459432 0.87 TP53 (0.43) MAPTNPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL29293072 0.87 ALDH1A1 (0.48) VSIRMAPTNPC1ALDH1A1RAB9A
SCHEMBL25753261 0.86 RAB9A (0.49) MAPTNPC1ALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed
EP-4181655-A1 ORGANIC LIGHT EMITTING ELEMENT LG Display Co., Ltd. (KR) 2023-05-17 EP disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX VSIR 4202/4885PDCD1 1204/4885CD274 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.